CA2736263C - Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent - Google Patents

Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent Download PDF

Info

Publication number
CA2736263C
CA2736263C CA2736263A CA2736263A CA2736263C CA 2736263 C CA2736263 C CA 2736263C CA 2736263 A CA2736263 A CA 2736263A CA 2736263 A CA2736263 A CA 2736263A CA 2736263 C CA2736263 C CA 2736263C
Authority
CA
Canada
Prior art keywords
composition
imidacloprid
blood
sucking
use according
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Active
Application number
CA2736263A
Other languages
English (en)
French (fr)
Other versions
CA2736263A1 (en
Inventor
Roland H. Johnson
Douglas I. Hepler
Kathleen G. Palma
William R. Campbell
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Bayer BV
Original Assignee
Bayer BV
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Bayer BV filed Critical Bayer BV
Publication of CA2736263A1 publication Critical patent/CA2736263A1/en
Application granted granted Critical
Publication of CA2736263C publication Critical patent/CA2736263C/en
Active legal-status Critical Current
Anticipated expiration legal-status Critical

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A61K31/4427—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems
    • A61K31/4439—Non condensed pyridines; Hydrogenated derivatives thereof containing further heterocyclic ring systems containing a five-membered ring with nitrogen as a ring hetero atom, e.g. omeprazole
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
    • A61K31/44—Non condensed pyridines; Hydrogenated derivatives thereof
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/415—1,2-Diazoles
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A61K9/0056—Mouth soluble or dispersible forms; Suckable, eatable, chewable coherent forms; Forms rapidly disintegrating in the mouth; Lozenges; Lollipops; Bite capsules; Baked products; Baits or other oral forms for animals
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/10—Anthelmintics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P33/00—Antiparasitic agents
    • A61P33/14—Ectoparasiticides, e.g. scabicides

Landscapes

  • Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Public Health (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Epidemiology (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Zoology (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Agricultural Chemicals And Associated Chemicals (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
CA2736263A 2008-10-03 2009-09-30 Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent Active CA2736263C (en)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US10277408P 2008-10-03 2008-10-03
US61/102,774 2008-10-03
PCT/US2009/059111 WO2010039892A1 (en) 2008-10-03 2009-09-30 Systemic treatment of blood-sucking and blood-consuming parasites oral administration of a parasiticidal agent

Publications (2)

Publication Number Publication Date
CA2736263A1 CA2736263A1 (en) 2010-04-08
CA2736263C true CA2736263C (en) 2020-01-14

Family

ID=42073871

Family Applications (1)

Application Number Title Priority Date Filing Date
CA2736263A Active CA2736263C (en) 2008-10-03 2009-09-30 Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent

Country Status (29)

Country Link
US (2) US9820977B2 (pl)
EP (1) EP2349265B1 (pl)
JP (3) JP6110065B2 (pl)
KR (3) KR20110067048A (pl)
CN (2) CN107041887A (pl)
AU (1) AU2009298541B2 (pl)
BR (1) BRPI0920434B1 (pl)
CA (1) CA2736263C (pl)
CL (1) CL2011000713A1 (pl)
CO (1) CO6361913A2 (pl)
DK (1) DK2349265T3 (pl)
EC (1) ECSP11011023A (pl)
ES (1) ES2588152T3 (pl)
HR (1) HRP20161082T1 (pl)
HU (1) HUE030412T2 (pl)
IL (1) IL211624B (pl)
MX (1) MX2011003415A (pl)
NI (1) NI201100067A (pl)
NZ (1) NZ592010A (pl)
PE (1) PE20110395A1 (pl)
PH (1) PH12011500679A1 (pl)
PL (1) PL2349265T3 (pl)
PT (1) PT2349265T (pl)
RU (1) RU2526169C2 (pl)
SI (1) SI2349265T1 (pl)
SV (1) SV2011003871A (pl)
UA (1) UA102565C2 (pl)
WO (1) WO2010039892A1 (pl)
ZA (1) ZA201102077B (pl)

Families Citing this family (16)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AP3517A (en) * 2010-04-22 2016-01-11 Genesis Lab Inc Compositions and methods for control of sand flies and other blood sucking insects.
US20120321703A1 (en) * 2011-06-16 2012-12-20 Daniel Kouri Capsule for oral pet medicine
EP2833866B2 (en) 2012-04-04 2024-11-27 Intervet International B.V. Soft chewable pharmaceutical products
US9504656B2 (en) * 2013-10-21 2016-11-29 Banner Life Sciences, LLC Pharmaceutical compositions for poorly soluble active ingredients
CN107835818B (zh) 2015-05-20 2022-04-29 勃林格殷格翰动物保健美国公司 驱虫缩酚酸肽化合物
WO2017106812A1 (en) 2015-12-19 2017-06-22 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
US20190022013A1 (en) 2015-12-19 2019-01-24 First Time Us Generics Llc Soft-chew tablet pharmaceutical formulations
UY40429A (es) 2016-02-24 2023-10-13 Boehringer Ingelheim Animal Health Usa Inc Compuestos antiparasitarios de isoxazolina, formulaciones inyectables de acción prolongada que los comprenden, métodos y usos de los mismos
WO2018039508A1 (en) 2016-08-25 2018-03-01 Merial, Inc. Method for reducing unwanted effects in parasiticidal treatments
MX2019005040A (es) * 2016-10-31 2019-10-30 Tropiq Health Sciences Métodos y composiciones para prevenir la transmisión de enfermedades vectoriales.
EP3541789A1 (en) 2016-11-16 2019-09-25 Boehringer Ingelheim Animal Health USA Inc. Anthelmintic depsipeptide compounds
US12269822B2 (en) 2018-07-09 2025-04-08 Boehringer Ingelheim Animal Health USA Inc. Anthelminthic heterocyclic compounds
WO2020112374A1 (en) 2018-11-20 2020-06-04 Boehringer Ingelheim Animal Health USA Inc. Indazolylcyanoethylamino compound, compositions of same, method of making, and methods of using thereof
MX2021011302A (es) 2019-03-19 2022-01-19 Boehringer Ingelheim Animal Health Usa Inc Compuestos de aza-benzotiofeno y aza-benzofurano como antihelminticos.
KR102659363B1 (ko) 2020-05-26 2024-04-22 주식회사 경보제약 동물에서의 기생충 감염 질환을 치료 또는 예방하기 위한 수의학적 구강붕해필름 제제
KR20230028268A (ko) 2020-05-29 2023-02-28 뵈링거 잉겔하임 애니멀 헬스 유에스에이 인코포레이티드 구충성 헤테로시클릭 화합물

Family Cites Families (20)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
DE4419814A1 (de) * 1994-06-07 1995-12-14 Bayer Ag Endoparasitizide
US6140350A (en) 1998-06-08 2000-10-31 Sumitomo Chemical Company, Limited Method for controlling ectoparasites
JP4538863B2 (ja) * 1998-06-08 2010-09-08 住友化学株式会社 寄生虫の駆除方法
JP2000062271A (ja) 1998-08-17 2000-02-29 Murata Mach Ltd 記録装置
DE122011100022I1 (de) 1999-08-12 2011-10-20 Lilly Co Eli Verwendung von Spinosad oder einer Zusammensetzungenthaltend spinosad.
US6787342B2 (en) 2000-02-16 2004-09-07 Merial Limited Paste formulations
JP4972843B2 (ja) 2000-11-09 2012-07-11 住友化学株式会社 動物外部寄生虫防除用経皮投与剤
CN1386420A (zh) 2001-05-22 2002-12-25 王玉万 一种含吡虫啉的宠物用抗寄生虫药
UA80096C2 (en) 2001-07-05 2007-08-27 Mikkel Sa Fencing for preventing insects to enter
MXPA04006002A (es) 2001-12-21 2004-09-27 Rhodia Composiciones tensioactivas estables para suspender componentes.
US7943160B2 (en) * 2002-05-09 2011-05-17 Scimetrics Limited Corp. Pest control methods
US20040037869A1 (en) * 2002-08-16 2004-02-26 Douglas Cleverly Non-animal product containing veterinary formulations
US7648711B2 (en) 2003-05-25 2010-01-19 Yuwan Wang Dimethicone-containing sustained release injection formulation
US20050158367A1 (en) * 2004-01-16 2005-07-21 The Procter & Gamble Company Liquid compositions comprising one or more medicaments
US20050234119A1 (en) 2004-04-16 2005-10-20 Soll Mark D Antiparasitical agents and methods for treating, preventing and controlling external parasites in animals
MX2007005617A (es) 2004-11-11 2007-07-09 Merial Ltd Derivados de vinilaminopirazol como pesticidas.
UY28617A1 (es) * 2004-11-12 2006-06-30 Popley Pharma Ltda Nuevas composiciones
MX2007008837A (es) 2005-01-21 2008-01-22 Merial Ltd Compuestos quimicos, procesos para su preparacion y uso de los mismos.
TWI412322B (zh) * 2005-12-30 2013-10-21 Du Pont 控制無脊椎害蟲之異唑啉
US7919522B2 (en) * 2007-05-03 2011-04-05 Merial Limited Compositions comprising C-13 alkoxyether macrolide compounds and phenylpyrazole compounds

Also Published As

Publication number Publication date
SV2011003871A (es) 2011-08-22
US20100087492A1 (en) 2010-04-08
UA102565C2 (ru) 2013-07-25
JP2016179983A (ja) 2016-10-13
JP6388890B2 (ja) 2018-09-12
CO6361913A2 (es) 2012-01-20
KR20110067048A (ko) 2011-06-20
NI201100067A (es) 2012-03-15
HUE030412T2 (hu) 2017-05-29
PH12011500679A1 (en) 2012-11-12
US20180078537A1 (en) 2018-03-22
AU2009298541B2 (en) 2015-03-26
US9820977B2 (en) 2017-11-21
EP2349265A4 (en) 2012-10-24
EP2349265A1 (en) 2011-08-03
PT2349265T (pt) 2016-08-31
NZ592010A (en) 2012-07-27
MX2011003415A (es) 2011-08-12
WO2010039892A1 (en) 2010-04-08
HRP20161082T1 (hr) 2016-10-21
BRPI0920434B1 (pt) 2021-07-27
RU2526169C2 (ru) 2014-08-20
CN107041887A (zh) 2017-08-15
SI2349265T1 (sl) 2016-10-28
ES2588152T3 (es) 2016-10-31
RU2011117203A (ru) 2012-11-10
ZA201102077B (en) 2012-12-27
IL211624A0 (en) 2011-05-31
ECSP11011023A (es) 2011-06-30
KR101903313B1 (ko) 2018-10-01
JP2012504636A (ja) 2012-02-23
JP6110065B2 (ja) 2017-04-05
CL2011000713A1 (es) 2011-08-26
WO2010039892A8 (en) 2011-03-24
JP2018127468A (ja) 2018-08-16
PL2349265T3 (pl) 2017-01-31
BRPI0920434A2 (pt) 2015-12-22
KR20170118235A (ko) 2017-10-24
KR101787917B1 (ko) 2017-10-18
KR20160011711A (ko) 2016-02-01
PE20110395A1 (es) 2011-06-19
IL211624B (en) 2018-01-31
CA2736263A1 (en) 2010-04-08
EP2349265B1 (en) 2016-05-25
CN102170880A (zh) 2011-08-31
AU2009298541A1 (en) 2010-04-08
DK2349265T3 (en) 2016-09-05

Similar Documents

Publication Publication Date Title
CA2736263C (en) Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent
CA2965524C (en) Palatable chewable veterinary composition
JP7241170B2 (ja) 食味の良い抗寄生虫製剤
CN110022862B (zh) 药物制剂及其制造方法
HK1236116A1 (en) Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent
HK1157641A (en) Systemic treatment of blood-sucking and blood-consuming parasites by oral administration of a parasiticidal agent
US20240226002A9 (en) Soft chewable formulations with active ingredients
US20140235688A1 (en) Treatment of external parasites by oral administration of parasiticidal agents
HK40011796A (en) Pharmaceutical preparation and method for its manufacture
BR112021004218B1 (pt) Composição veterinária de comprimido mastigável, duro e palatável e uso da mesma para tratar ou prevenir uma infecção ou infestação parasitária em um animal

Legal Events

Date Code Title Description
EEER Examination request

Effective date: 20140819

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 15TH ANNIV.) - STANDARD

Year of fee payment: 15

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20240826

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT DETERMINED COMPLIANT

Effective date: 20240826

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20240826

MPN Maintenance fee for patent paid

Free format text: FEE DESCRIPTION TEXT: MF (PATENT, 16TH ANNIV.) - STANDARD

Year of fee payment: 16

U00 Fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U00-U101 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE REQUEST RECEIVED

Effective date: 20250821

U11 Full renewal or maintenance fee paid

Free format text: ST27 STATUS EVENT CODE: A-4-4-U10-U11-U102 (AS PROVIDED BY THE NATIONAL OFFICE); EVENT TEXT: MAINTENANCE FEE PAYMENT PAID IN FULL

Effective date: 20250821